Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Ting Song, Xiao Xin, Peirong Cui, Mingcan Zong & Xianhua Li. (2021) Factors Associated with Anticoagulation Adherence in Chinese Patients with Non-Valvular Atrial Fibrillation. Patient Preference and Adherence 15, pages 493-500.
Read now
Read now
Muhammad Maqsood, Muhammad Imran Hasan Khan, Mubashar Yameen, Kashif Aziz Ahmed, Nazim Hussain & Safdar Hussain. (2021) Use of oral rivaroxaban in cerebral venous thrombosis. Journal of Drug Assessment 10:1, pages 1-6.
Read now
Read now
Xiao-Qin Liu, Yi-Wei Yin, Chen-Yu Wang, Zi-Ran Li, Xiao Zhu & Zheng Jiao. (2021) How to handle the delayed or missed dose of rivaroxaban in patients with non-valvular atrial fibrillation: model-informed remedial dosing. Expert Review of Clinical Pharmacology 14:9, pages 1153-1163.
Read now
Read now
Articles from other publishers (34)
Vasiliki Danilatou, Dimitrios Dimopoulos, Theodoros Kostoulas & James Douketis. (2024) Machine Learning-Based Predictive Models for Patients with Venous Thromboembolism: A Systematic Review. Thrombosis and Haemostasis.
Crossref
Crossref
Jan Bosák, Martin Šíma, Tereza Krejčí, Iva Obadalová, Jaroslava Šmardová, Petr Kozlík, Tomáš Křížek, Josef Beránek, Tomáš Hauser & Ondřej Slanař. (2024) Development of immediate‐release formulation with reliable absorption of rivaroxaban in various meal regimes. Clinical and Translational Science 17:5.
Crossref
Crossref
Maria Giner-Soriano, Dan Ouchi, Roser Vives, Carles Vilaplana-Carnerero, Andrea Molina, Antoni Vallano & Rosa Morros. (2023) Effectiveness and safety of oral anticoagulants for non-valvular atrial fibrillation: a population-based cohort study in primary healthcare in Catalonia. Frontiers in Pharmacology 14.
Crossref
Crossref
Maxim Grymonprez, Stephane Steurbaut, Andreas Capiau, Delphine Vauterin, Frauke Van Vaerenbergh, Els Mehuys, Koen Boussery, Tine L. De Backer & Lies Lahousse. (2023) Minimal Adherence Threshold to Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation to Reduce the Risk of Thromboembolism and Death: A Nationwide Cohort Study. Cardiovascular Drugs and Therapy.
Crossref
Crossref
Yi‐wei Yin, Xiao‐qin Liu, Jia‐qin Gu, Zi‐ran Li & Zheng Jiao. (2022) How to handle a delayed or missed dose of edoxaban in patients with non‐valvular atrial fibrillation? A model‐informed remedial strategy. British Journal of Clinical Pharmacology 89:7, pages 2066-2075.
Crossref
Crossref
Sabine F. B. van der Horst, Tim A.C. de Vries, Gordon Chu, Roisin Bavalia, Helen Xiong, Kayleigh M. van de Wiel, Kelly Mulder, Hanne van Ballegooijen, Joris R. de Groot, Saskia Middeldorp, Frederikus A. Klok, Martin E.W. Hemels & Menno V. Huisman. (2023) Prevalence and Predictors of Nonadherence to Direct Oral Anticoagulant Treatment in Patients with Atrial Fibrillation. TH Open 07:03, pages e270-e279.
Crossref
Crossref
Okti Ratna Mafruhah, Yen-Ming Huang & Hsiang-Wen Lin. (2023) Impacts of medication non-adherence to major modifiable stroke-related diseases on stroke prevention and mortality: a meta-analysis. Journal of Neurology 270:5, pages 2504-2516.
Crossref
Crossref
Won Kyung Lee, Seong Ill Woo, Dong Keun Hyun, Sun-Young Jung, Mi-sook Kim & Joongyub Lee. (2023) Impact of treatment adherence on the effectiveness and safety of oral anticoagulants in patients with atrial fibrillation: a retrospective cohort study. European Heart Journal - Quality of Care and Clinical Outcomes 9:3, pages 216-226.
Crossref
Crossref
Fang Li, Changkun Wei, Su Huo, Xiuzhen Liu & Jubao Du. (2023) Predictors of deep-vein thrombosis for acute stroke at admission to a rehabilitation unit: A retrospective study. Frontiers in Neurology 14.
Crossref
Crossref
Hui-Jeong Hwang, Il Suk Sohn, Eun-Sun Jin & Yoon-Jong Bae. (2023) Adherence and clinical outcomes for twice-daily versus once-daily dosing of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: Is dosing frequency important?. PLOS ONE 18:3, pages e0283478.
Crossref
Crossref
Piotr Merks, Jameason D. Cameron, Marcin Balcerzak, Urszula Religioni, Damian Świeczkowski, Mikołaj Konstanty, Dagmara Hering, Filip M. Szymański, Milosz Jaguszewski & Régis Vaillancourt. (2022) Evaluation of a pharmacist-led intervention to improve medication adherence in patients initiating dabigatran treatment: a comparison with standard pharmacy practice in Poland. BMC Primary Care 23:1.
Crossref
Crossref
Mirela Marioara Toma, Simona Gabriela Bungau, Delia Mirela Tit, Madalina Ioana Moisi, Cristiana Bustea, Cosmin Mihai Vesa, Tapan Behl, Manuela Stoicescu, Cristina Mihaela Brisc, Lavinia Anamaria Purza, Daniela Gitea & Camelia Cristina Diaconu. (2022) Use of anticoagulant drugs in patients with atrial fibrillation. Does adherence to therapy have a prognostic impact?. Biomedicine & Pharmacotherapy 150, pages 113002.
Crossref
Crossref
Myrthe M A Toorop, Qingui Chen, Vladimir Y I G Tichelaar, Suzanne C Cannegieter & Willem M Lijfering. (2021) Predictors, time course, and outcomes of persistence patterns in oral anticoagulation for non-valvular atrial fibrillation: a Dutch Nationwide Cohort Study. European Heart Journal 42:40, pages 4126-4137.
Crossref
Crossref
Yuuki Akagi, Akiko Iketaki, Reiko Nakamura, Shigeo Yamamura, Minori Endo, Keisuke Morikawa, Shun Oikawa, Takahiro Ohta, Shimpei Tatsumi, Takafumi Suzuki, Atsuhiro Mizushima, Keiichi Koido & Tatsuya Takahashi. (2021) Association between Cerebral Infarction Risk and Medication Adherence in Atrial Fibrillation Patients Taking Direct Oral Anticoagulants. Healthcare 9:10, pages 1313.
Crossref
Crossref
Naoharu Yagi, Shinya Suzuki, Katsuhiko Nagai, Takashi Tanaka, Takayoshi Nagahama, Takuto Arita, Takayuki Otsuka & Takeshi Yamashita. (2021) Current status of oral anticoagulant adherence in Japanese patients with atrial fibrillation: A claims database analysis. Journal of Cardiology 78:2, pages 150-156.
Crossref
Crossref
Gilda D. Zielinski, Nienke van Rein, Martina Teichert, Frederikus A. Klok, Frits R. Rosendaal, Felix J. M. van der Meer, Menno V. Huisman, Suzanne C. Cannegieter & Willem M. Lijfering. (2021) Adherence to direct oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study. Pharmacoepidemiology and Drug Safety 30:8, pages 1027-1036.
Crossref
Crossref
Ben Freedman, Gerhard Hindricks, Amitava Banerjee, Adrian Baranchuk, Chi Keong Ching, Xin Du, Donna Fitzsimons, Jeff S. Healey, Takanori Ikeda, Trudie C. A. Lobban, Amam Mbakwem, Calambur Narasimhan, Lis Neubeck, Peter Noseworthy, Daniel M. PhilbinJr.Jr., Fausto J. Pinto, Joselyn Rwebembera, Renate B. Schnabel, Jesper Hastrup Svendsen, Luis Aguinaga, Elena Arbelo, Michael Böhm, Hasan Ali Farhan, F. D. Richard Hobbs, Antoni Martínez-Rubio, Claudio Militello, Nitish Naik, Jean Jacques Noubiap, Pablo Perel, Daniel José Piñeiro, Antonio Luiz Ribeiro & Janina Stepinska. (2021) World Heart Federation Roadmap on Atrial Fibrillation – A 2020 Update. Global Heart 16:1.
Crossref
Crossref
Yucai Huang, Cuirong Guo, Kun Song, Changluo Li & Ning Ding. (2021) Association of clinical and laboratory variables with in-hospital incidence of deep vein thrombosis in patients after acute ischemic stroke. Medicine 100:6, pages e24601.
Crossref
Crossref
Jongmin Hwang, So-Ryoung Lee, Hyoung-Seob Park, Young Soo Lee, Jin Hee Ahn, Jong-Il Choi, Dong Gu Shin, Dae-Kyeong Kim, Jong Sung Park, Ki Won Hwang, Tae-Joon Cha, Eue-Keun Choi & Seongwook Han. (2021) Adherence to dabigatran and the influence of dabigatran-induced gastrointestinal discomfort in the real-world practice. International Journal of Cardiology 323, pages 77-82.
Crossref
Crossref
Vivencio Barrios, Carlos Escobar, Gonzalo Barón, Juanjo Gómez‐Doblas, Esther Recalde, Luis Segura, Pere Alvarez, Francisco Alonso, Jesús Toril & José Miguel Chopo. (2020) Quality of life, medication adherence and satisfaction with anticoagulant treatment (dabigatran vs vitamin K antagonists) according to thromboembolic risk. Data from the CAPANA study. International Journal of Clinical Practice 74:11.
Crossref
Crossref
Yutao Guo, Deirdre A. Lane, Yundai Chen & Gregory Y.H. Lip. (2020) Regular Bleeding Risk Assessment Associated with Reduction in Bleeding Outcomes: The mAFA-II Randomized Trial. The American Journal of Medicine 133:10, pages 1195-1202.e2.
Crossref
Crossref
Adrienne Pacleb, Nicole Lowres, Sue Randall, Lis Neubeck & Robyn Gallagher. (2020) Adherence to Cardiac Medications in Patients With Atrial Fibrillation: A Pilot Study. Heart, Lung and Circulation 29:7, pages e131-e139.
Crossref
Crossref
Vivencio Barrios, Carlos Escobar, Juan José Gómez-Doblas, Jaime Fernández-Dueñas, Rafael Romero Garrido, Javier Pindado Rodríguez, Juana Umarán Sánchez, Eduardo Arellano-Rodrigo & Esther Donado. (2020) Patients’ perceptions with dabigatran in patients with atrial fibrillation previously treated with vitamin K antagonists. Journal of Comparative Effectiveness Research 9:9, pages 615-625.
Crossref
Crossref
Shahrzad Salmasi, Peter S Loewen, Rachel Tandun, Jason G Andrade & Mary A De Vera. (2020) Adherence to oral anticoagulants among patients with atrial fibrillation: a systematic review and meta-analysis of observational studies. BMJ Open 10:4, pages e034778.
Crossref
Crossref
Aya F. OzakiAustin S. ChoiQuan T. LeDennis T. KoJanet K. HanSandy S. ParkCynthia A. Jackevicius. (2020) Real-World Adherence and Persistence to Direct Oral Anticoagulants in Patients With Atrial Fibrillation. Circulation: Cardiovascular Quality and Outcomes 13:3.
Crossref
Crossref
S. G. Kanorskii. (2019) How to maintain an adherence to oral anticoagulant in a patient with atrial fibrillation?. Kardiologiia 59:11, pages 76-83.
Crossref
Crossref
T. A. C. de Vries & J. R. de Groot. (2019) Experience with non-vitamin K antagonists in the Netherlands: stories from both sides of the desk. Netherlands Heart Journal 27:12, pages 587-589.
Crossref
Crossref
Ana Ruigómez, Pareen Vora, Yanina Balabanova, Gunnar Brobert, Luke Roberts, Samuel Fatoba, Oscar Fernandez & Luis Alberto García Rodríguez. (2019) Discontinuation of non-Vitamin K antagonist oral anticoagulants in patients with non-valvular atrial fibrillation: a population-based cohort study using primary care data from The Health Improvement Network in the UK. BMJ Open 9:10, pages e031342.
Crossref
Crossref
V. Barrios, C. Escobar, G. Barón Esquivias, J.J. Gómez Doblas, E. Recalde del Vigo, L. Segura Martínez, P. Alvarez Garcia, F. Alonso Valladares, J. Toril Lopez & J.M. Chopo Alcubilla. (2019) Quality of life, adherence and satisfaction of patients with auricular fibrillation treated with dabigatran or vitamin K antagonists. Revista Clínica Española (English Edition) 219:6, pages 285-292.
Crossref
Crossref
V. Barrios, C. Escobar, G. Barón Esquivias, J.J. Gómez Doblas, E. Recalde del Vigo, L. Segura Martínez, P. Alvarez Garcia, F. Alonso Valladares, J. Toril Lopez & J.M. Chopo Alcubilla. (2019) Calidad de vida, adherencia y satisfacción en pacientes con fibrilación auricular tratados con dabigatrán o antagonistas de la vitamina K. Revista Clínica Española 219:6, pages 285-292.
Crossref
Crossref
Alan Rodrigues Andrade, Daniel da Silva Leitão, Igor Penha Paz, Talitta Ribeiro Evangelista, Vanessa Joia de Mello & Moisés Hamoy. (2019) Analysis of imatinib adherence in chronic myeloid leukemia: a retrospective study in a referral hospital in the Brazilian Amazon. Hematology, Transfusion and Cell Therapy 41:2, pages 106-113.
Crossref
Crossref
Nicole Lowres, Katrina Giskes, Charlotte Hespe & Ben Freedman. (2019) Reducing Stroke Risk in Atrial Fibrillation: Adherence to Guidelines Has Improved, but Patient Persistence with Anticoagulant Therapy Remains Suboptimal. Korean Circulation Journal 49:10, pages 883.
Crossref
Crossref
Isabel Hurtado-Navarro, Aníbal García-Sempere, Clara Rodríguez-Bernal, Yared Santa-Ana-Tellez, Salvador Peiró & Gabriel Sanfélix-Gimeno. (2018) Estimating Adherence Based on Prescription or Dispensation Information: Impact on Thresholds and Outcomes. A Real-World Study With Atrial Fibrillation Patients Treated With Oral Anticoagulants in Spain. Frontiers in Pharmacology 9.
Crossref
Crossref
Clara L Rodríguez-Bernal, Aníbal García-Sempere, Isabel Hurtado, Yared Santa-Ana, Salvador Peiró & Gabriel Sanfélix-Gimeno. (2018) Real-world adherence to oral anticoagulants in atrial fibrillation patients: a study protocol for a systematic review and meta-analysis. BMJ Open 8:12, pages e025102.
Crossref
Crossref